Money, Pharmaceuticals and health products
Sarepta Therapeutics, Inc. Political Action Committee (Sarepta PAC)
Corporation, Sausalito, CA. FEC committee C00850339.
Sarepta Therapeutics, Inc. Political Action Committee (Sarepta PAC) is a political action committee sponsored by a company in the pharmaceuticals and health products field. It collects voluntary contributions from the organization's employees or members and gives them to candidates. Since 2021 it has given $40K to members of Congress. 68% of its money in 2025-26 helped Republicans.
Who its money helped, 2025-26
32% Democrats $7K68% Republicans $15K
2026 scorecard
- Went its way
- Did not
- Spent on 2026 races
- $22K
- PAC gifts and outside spending for or against House and Senate candidates
- Races that went its way
- 10 of 13
- 77% of the races it put money into
- Money on the winning side
- 80%
- $14K on winners, $4K on losers
- Spent on 2026 general elections
- $3K
- PAC gifts and outside spending for or against House and Senate candidates
- Races that went its way
- 1 of 2
- 50% of the races it put money into
- Money on the winning side
- 40%
- $1K on winners, $2K on losers
- Spent on 2026 primaries
- $20K
- PAC gifts and outside spending for or against House and Senate candidates
- Races that went its way
- 9 of 11
- 82% of the races it put money into
- Money on the winning side
- 87%
- $13K on winners, $2K on losers
- Given to members
- $2K
- 2 recipients in 2026
- To Democrats
- 50%
- $1K
- To Republicans
- 50%
- $1K
- Lobbying, 2025-26
- $1.89M
- Lobbying Disclosure Act filings
Recipients
Share is the gift's part of everything that member raised in the 2025-26 cycle. Open a row for every contribution.
| Member | Given | Share | 2026 race |
|---|---|---|---|
Rep. Doris O. MatsuiD California 7th4 contributions, 2024 to 20262023-24: $2,0002025-26: $2,000
| $1,000 | <0.1% | Won |
Rep. Gus M. BilirakisR Florida 12th3 contributions, 2024 to 20262023-24: $2,0002025-26: $1,000
| $1,000 | <0.1% | Won |
What Sarepta Therapeutics lobbies on
Bills named in filings: H.R. 1509, H.R. 9260.

